SUN NELSON (Chief Financial Officer) purchased 6.0% of their position (6K shares) of AARDVARK THERAPEUTICS, INC. on the open market
Open‑market purchase worth $48.4K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/10/2025ACC: 0001193125-25-200226
Officer· Chief Financial Officer
Since Feb 2026
+6K
Net shares
Net buyer
$48.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6K
Price / share
$8.07
Trade value
$48.44K
% of position
6.0%
9/9/2025
99.48K→105.48K
Total
Net shares
+6K
Net value
$48.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2025 | P · Purchase | +6K | $8.07 | $48.44K | 6.0% | 99.48K | 105.48K |
| Total | +6K | $48.44K | ||||||
Derivative Transactions0
No derivative transactions reported